Mutual Fund Details

SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout

Name: SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout
Brand: SBI Mutual Fund

Equity Pharma

NAV

₹334.7332

as on 25 Nov 2024, 09:00 PM

₹4.8837(1.48%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Schemes Managed By

Tanmaya Desai

Fund Manager

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,89,950

₹1,96,134

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹96,134

Profit (absolute return)

96.13%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

6.53%

In the last 6 months

24.33%

In the last 1 year

47.28%

In the last 3 years

96.13%

In the last 5 years

275.42%

In the last 10 years

306.18%

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout

as of 31 Oct 2024, 05:30 AM

₹3,416.13 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 0.50% if redeemed within 15 days

0.89%

Expense Ratio

Plan

Dividend

3.27%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 0.50% if redeemed within 15 days

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

93.23%

₹3,184.86 Cr

Chemicals

3.50%

₹119.56 Cr

Others

3.27%

₹111.71 Cr

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

93.23%

₹3,184.86 Cr

Chemicals

3.50%

₹119.56 Cr

Others

3.27%

₹111.71 Cr

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹470.74 Cr

Max Healthcare Institute Ltd.

7.67%

₹262.02 Cr

Divi's Laboratories Ltd.

6.66%

₹227.51 Cr

Cipla Ltd.

6.65%

₹227.17 Cr

Lonza Group Ag

4.94%

₹168.76 Cr

Others

60.30%

₹2,059.93 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

13.78%

₹470.74 Cr

Max Healthcare Institute Ltd.

7.67%

₹262.02 Cr

Divi's Laboratories Ltd.

6.66%

₹227.51 Cr

Cipla Ltd.

6.65%

₹227.17 Cr

Lonza Group Ag

4.94%

₹168.76 Cr

Others

60.30%

₹2,059.93 Cr

View All

Funds in this Category

This fund's returns:

25.15%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

About SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout

SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout is a Equity mutual fund scheme from SBI Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Tanmaya Desai. It has an AUM of ₹3,416.13 Crores and the latest NAV decalared is ₹334.733 as on 27 Nov 2024 at 8:08 am.

SBI Healthcare Opportunities Fund Direct Plan-IDCW Payout scheme return performance in last 1 year is 47.28%, in last 3 years is 96.13% and 697.21% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.